Walleye Capital LLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $5.55 Million - $6.49 Million	56,100 Added 5100.0%	57,200 $6.62 Million
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $38,536 - $44,952	-400 Reduced 26.67%	1,100 $113,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $93,585 - $170,700	1,500 New	1,500 $170,000
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $12,435 - $19,280	-500 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $610,320 - $880,080	-24,000 Reduced 97.96%	500 $18,000

Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $101,200 - $123,068	4,400 Added 21.89%	24,500 $667,000
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $458,481 - $572,448	20,100 New	20,100 $484,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.